These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9269624)

  • 1. Alport syndrome--is there a genotype-phenotype relationship?
    Turco AE; Renieri A; De Marchi M
    Nephrol Dial Transplant; 1997 Aug; 12(8):1551-3. PubMed ID: 9269624
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical spectrum of type IV collagen mutations.
    Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
    Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis.
    Antignac C; Heidet L
    Contrib Nephrol; 1996; 117():172-82. PubMed ID: 8801045
    [No Abstract]   [Full Text] [Related]  

  • 4. Alport syndrome with diffuse leiomyomatosis. When and when not?
    Miner JH
    Am J Pathol; 1999 Jun; 154(6):1633-5. PubMed ID: 10362786
    [No Abstract]   [Full Text] [Related]  

  • 5. Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome.
    Renieri A; Galli L; Grillo A; Bruttini M; Neri T; Zanelli P; Rizzoni G; Massella L; Sessa A; Meroni M; Peratoner L; Riegler P; Scolari F; Mileti M; Giani M; Cossu M; Savi M; Ballabio A; De Marchi M
    Am J Med Genet; 1995 Nov; 59(3):380-5. PubMed ID: 8599366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Esophageal leiomyomatosis revealing an Alport syndrome].
    Abbes K; Ayadi L; Makni S; Kharrat M; Affes N; Kallel R; Gouiaa N; Ben Hmida M; Hachicha J; Beyrouti MI; Sellami Boudawara T
    Rev Med Interne; 2009 Jan; 30(1):88-90. PubMed ID: 18433941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alport syndrome and diffuse leiomyomatosis with major morbid events presenting at adult age.
    Van Loo A; Vanholder R; Buytaert I; De Paepe A; Praet M; Elewaut A; Lameire N
    Nephrol Dial Transplant; 1997 Apr; 12(4):776-80. PubMed ID: 9141011
    [No Abstract]   [Full Text] [Related]  

  • 8. Alport syndrome and benign familial hematuria (thin basement membrane disease) in two brothers of a family with hematuria.
    Takemura T; Yanagida H; Yagi K; Moriwaki K; Okada M
    Clin Nephrol; 2003 Sep; 60(3):195-200. PubMed ID: 14524583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.
    Lemmink HH; Nillesen WN; Mochizuki T; Schröder CH; Brunner HG; van Oost BA; Monnens LA; Smeets HJ
    J Clin Invest; 1996 Sep; 98(5):1114-8. PubMed ID: 8787673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in Alport syndrome: the cross-fertilisation between genetics and clinical medicine.
    Pirson Y
    Acta Clin Belg; 1997; 52(4):233-40. PubMed ID: 9351295
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region.
    Heidet L; Cohen-Solal L; Boye E; Thorner P; Kemper MJ; David A; Larget Piet L; Zhou J; Flinter F; Zhang X; Gubler MC; Antignac C
    Cytogenet Cell Genet; 1997; 78(3-4):240-6. PubMed ID: 9465897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis.
    Garcia-Torres R; Cruz D; Orozco L; Heidet L; Gubler MC
    Nephrologie; 2000; 21(1):9-12. PubMed ID: 10730274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of the alpha6(IV) chain of collagen type IV in Alport syndrome is related to a failure at the protein assembly level and does not result in diffuse leiomyomatosis.
    Zheng K; Harvey S; Sado Y; Naito I; Ninomiya Y; Jacobs R; Thorner PS
    Am J Pathol; 1999 Jun; 154(6):1883-91. PubMed ID: 10362815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis.
    Hudson BG; Reeders ST; Tryggvason K
    J Biol Chem; 1993 Dec; 268(35):26033-6. PubMed ID: 8253711
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure of the human type IV collagen COL4A6 gene, which is mutated in Alport syndrome-associated leiomyomatosis.
    Zhang X; Zhou J; Reeders ST; Tryggvason K
    Genomics; 1996 May; 33(3):473-9. PubMed ID: 8661006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case report of Alport syndrome with esophageal leiomyomatosis].
    Chen Y; Li SL; Xiao HJ; Ding J
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):611. PubMed ID: 18082056
    [No Abstract]   [Full Text] [Related]  

  • 17. Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth.
    Thielen BK; Barker DF; Nelson RD; Zhou J; Kren SM; Segal Y
    Hum Mutat; 2003 Nov; 22(5):419. PubMed ID: 14517961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diffuse leiomyomatosis with genital involvement and Alport syndrome. Report of two cases].
    Le Bras A; David A; Knipping M; Mensier A; Heidet L; Lopes P
    J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):523-8. PubMed ID: 9791580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the 5'exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome.
    Sá MJ; Fieremans N; de Brouwer AP; Sousa R; e Costa FT; Brito MJ; Carvalho F; Rodrigues M; de Sousa FT; Felgueiras J; Neves F; Carvalho A; Ramos U; Vizcaíno JR; Alves S; Carvalho F; Froyen G; Oliveira JP
    J Med Genet; 2013 Nov; 50(11):745-53. PubMed ID: 23958657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
    Buzza M; Wang YY; Dagher H; Babon JJ; Cotton RG; Powell H; Dowling J; Savige J
    Kidney Int; 2001 Aug; 60(2):480-3. PubMed ID: 11473630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.